FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and concerns an agent expressing antithrombotic activity and containing an antagonist of purine R2U1-receptors, namely 2-(4-methoxyphenyl)-(9-morpholinoethyl)imidazo[1,2-a]benzimidazole dihydrochloride of formula 
.
EFFECT: there is described antithrombotic agent affecting regulation of thrombocyte capacity.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
| METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE | 2013 |
|
RU2518740C1 |
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
| PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
| MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
| AGENT SHOWING SEROTONIN 5-HT-RECEPTOR ANTAGONIST PROPERTIES | 2010 |
|
RU2438669C1 |
| HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
| 2-(3,4-DIHYDROXYPHENYL)-9-DIETHYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE DIHYDROBROMIDE AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2391979C2 |
